These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 7920747)
21. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases. Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700 [TBL] [Abstract][Full Text] [Related]
22. Changing rates of Helicobacter pylori testing and treatment in patients with peptic ulcer disease. Chiorean MV; Locke GR; Zinsmeister AR; Schleck CD; Melton LJ Am J Gastroenterol; 2002 Dec; 97(12):3015-22. PubMed ID: 12492184 [TBL] [Abstract][Full Text] [Related]
23. The health economics of Helicobacter pylori infection. Moayyedi P Best Pract Res Clin Gastroenterol; 2007; 21(2):347-61. PubMed ID: 17382282 [TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori and peptic ulcer disease. Feldman M; Peterson WL West J Med; 1993 Nov; 159(5):555-9. PubMed ID: 8279151 [TBL] [Abstract][Full Text] [Related]
25. Eradication of Helicobacter pylori improves the healing rate and reduces the relapse rate of nonbleeding ulcers in patients with bleeding peptic ulcer. Arkkila PE; Seppälä K; Kosunen TU; Haapiainen R; Kivilaakso E; Sipponen P; Mäkinen J; Nuutinen H; Rautelin H; Färkkilä MA Am J Gastroenterol; 2003 Oct; 98(10):2149-56. PubMed ID: 14572560 [TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis: a prospective single-center trial. Schilling D; Demel A; Nüsse T; Weidmann E; Riemann JF Endoscopy; 2003 May; 35(5):393-6. PubMed ID: 12701009 [TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome. Wheeldon TU; Hoang TT; Phung DC; Björkman A; Granström M; Sörberg M Aliment Pharmacol Ther; 2005 Apr; 21(8):1047-53. PubMed ID: 15813841 [TBL] [Abstract][Full Text] [Related]
28. Helicobacter pylori eradication in patients with peptic ulcer disease: clinical consequences and financial implications. Powell KU; Bell GD; Bolton GH; Burridge SM; Bowden AF; Rameh B; Hart L; Bradley P; Harrison G; Gant PW Q J Med; 1994 May; 87(5):283-90. PubMed ID: 7938408 [TBL] [Abstract][Full Text] [Related]
30. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S; J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773 [TBL] [Abstract][Full Text] [Related]
31. [Peptic ulcer disease etiology, diagnosis and treatment]. Bak-Romaniszyn L; Wojtuń S; Gil J; Płaneta-Małecka I Pol Merkur Lekarski; 2004; 17 Suppl 1():128-32. PubMed ID: 15603370 [TBL] [Abstract][Full Text] [Related]
32. Indications for treatment of Helicobacter pylori infection: a systematic overview. Veldhuyzen van Zanten SJ; Sherman PM CMAJ; 1994 Jan; 150(2):189-98. PubMed ID: 8287341 [TBL] [Abstract][Full Text] [Related]
33. The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting. Rosengren H; Polson RJ Br J Gen Pract; 1996 Mar; 46(404):177-9. PubMed ID: 8731626 [TBL] [Abstract][Full Text] [Related]
34. Effect of Helicobacter pylori eradication on the healing and recurrence of peptic ulcer: combination therapy with low-dose omeprazole and clarithromycin. Uemura N; Okamoto S; Mukai T; Yamaguchi S; Kaji M; Hrruma K; Sumii K; Kajiyama G Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S67-9. PubMed ID: 8574740 [TBL] [Abstract][Full Text] [Related]
35. Endoscopic findings and prevalence of Helicobacter pylori in Kenyan patients with dyspepsia. Ogutu EO; Kang'ethe SK; Nyabola L; Nyong'o A East Afr Med J; 1998 Feb; 75(2):85-9. PubMed ID: 9640829 [TBL] [Abstract][Full Text] [Related]
36. The prevalence and incidence of Helicobacter pylori-associated peptic ulcer disease and upper gastrointestinal bleeding throughout the world. Wang AY; Peura DA Gastrointest Endosc Clin N Am; 2011 Oct; 21(4):613-35. PubMed ID: 21944414 [TBL] [Abstract][Full Text] [Related]
37. Peptic ulcer disease: what is the role for Helicobacter pylori? Bourke B; Sherman P; Drumm B Semin Gastrointest Dis; 1994 Jan; 5(1):24-31. PubMed ID: 7915181 [No Abstract] [Full Text] [Related]
38. Summary of the NIH consensus. Helicobacter pylori in peptic ulcer disease. Md Med J; 1994 Oct; 43(10):923-4. PubMed ID: 7808195 [No Abstract] [Full Text] [Related]
39. [Reflections on the marked changes of the prevalence of Helicobacter pylori infection and peptic ulcer disease in the last two decades]. Bohumil F Cas Lek Cesk; 2011; 150(2):91-3. PubMed ID: 21560446 [TBL] [Abstract][Full Text] [Related]
40. Management of Helicobacter pylori infection in Latin America: a Delphi technique-based consensus. Rollan A; Arab JP; Camargo MC; Candia R; Harris P; Ferreccio C; Rabkin CS; Gana JC; Cortés P; Herrero R; Durán L; García A; Toledo C; Espino A; Lustig N; Sarfatis A; Figueroa C; Torres J; Riquelme A World J Gastroenterol; 2014 Aug; 20(31):10969-83. PubMed ID: 25152601 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]